Treatment of familial hypercholesterolemia in children. 1971

M M Segall, and A S Fosbrooke, and J K Lloyd, and O H Wolff

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008041 Linoleic Acids Eighteen-carbon essential fatty acids that contain two double bonds. Acids, Linoleic
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D009821 Oils Unctuous combustible substances that are liquid or easily liquefiable on warming, and are soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. Depending on their behavior on heating, they are volatile or fixed. (Dorland, 28th ed)
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl

Related Publications

M M Segall, and A S Fosbrooke, and J K Lloyd, and O H Wolff
May 2003, Expert review of cardiovascular therapy,
M M Segall, and A S Fosbrooke, and J K Lloyd, and O H Wolff
April 2020, International journal of cardiology,
M M Segall, and A S Fosbrooke, and J K Lloyd, and O H Wolff
January 1989, Arteriosclerosis (Dallas, Tex.),
M M Segall, and A S Fosbrooke, and J K Lloyd, and O H Wolff
August 2004, Current opinion in lipidology,
M M Segall, and A S Fosbrooke, and J K Lloyd, and O H Wolff
January 1996, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M M Segall, and A S Fosbrooke, and J K Lloyd, and O H Wolff
January 2016, Developmental period medicine,
M M Segall, and A S Fosbrooke, and J K Lloyd, and O H Wolff
January 2022, Pediatric endocrinology, diabetes, and metabolism,
M M Segall, and A S Fosbrooke, and J K Lloyd, and O H Wolff
September 2015, Current cardiology reports,
M M Segall, and A S Fosbrooke, and J K Lloyd, and O H Wolff
January 2018, Current pharmaceutical design,
M M Segall, and A S Fosbrooke, and J K Lloyd, and O H Wolff
March 1978, Pediatrics,
Copied contents to your clipboard!